Synlett
DOI: 10.1055/a-2706-0821
Synpacts

Total Synthesis of (±)-Phaeocaulisin A Enabled Chemistry Innovation and Biological Discovery

Authors

  • Chang Liu

    1   Department of Chemistry, Emory University, Atlanta, United States (Ringgold ID: RIN1371)
  • Mingyu Zhang

    1   Department of Chemistry, Emory University, Atlanta, United States (Ringgold ID: RIN1371)
  • Mingji Dai

    1   Department of Chemistry, Emory University, Atlanta, United States (Ringgold ID: RIN1371)
    2   Department of Pharmacology and Chemical Biology, School of Medicine, Emory University, Atlanta, United States

Funding Information NSF 2349014


Graphical Abstract

Preview

Abstract

Guaianolide sesquiterpene natural products are of great biological and synthetic importance. Among them, phaeocaulisin A with a unique tetracyclic skeleton was isolated in 2013 and found to exhibit anticancer cell proliferation activity and anti-inflammatory activity. The first total synthesis of ( )-phaeocaulisin A was achieved by Procter and coworkers in 2022. Two years later, we reported a total synthesis of ( ± )-phaeocaulisin A. The key steps of our total synthesis include a novel palladium-catalyzed cyclopropanol ring-opening carbonylative esterification to access a key γ-ketoester, a regio- and stereo-selective aldol cyclization to build the 7-membered carbocycle, and a cascade ketalization/lactonization to construct the tetracyclic skeleton. This Synpact article reflects our journey toward ( ± )-phaeocaulisin A, which also led to the discovery of an analogue with potent anticancer activity against triple negative or HER2+ breast cancer.



Publication History

Received: 06 July 2025

Accepted after revision: 28 August 2025

Accepted Manuscript online:
19 September 2025

Article published online:
24 October 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany